INCA wins award for Patient Survey
The International Neuroendocrine Cancer Alliance (INCA) has won a prestigious award for our abstract entitled “Patient Perspective and Quality of Life: US Results from the First Global Neuroendocrine Tumor Patient Survey”, which has been selected as an exceptional submission for Category III: Quality, Outcomes, and Performance Improvement.
Only one abstract has been awarded
Only one abstract for each category has been awarded this distinction. The award was collected on the 4th October from the Academy of Oncology Nurse & Patient navigator conference.
Congratulations to all of the INCA team, and thanks to Novartis for supporting this fantastic piece of work.
Photo: Teodora Kolarova, President of the International Neuroendocrine Cancer Alliance (INCA) presenting the survey at ESMO.